1. Effective long-term treatment of acromegaly with a long-acting somatostatin analogue;Sandler, L.M.; Burrin, J.M.; Williams, G.; Joplin, G.F.; Carr, D.H.; Bloom, SR;ClGn Endocrinol (Oxf),1987
2. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995;Lamberts, S.W.; Uitterlinden, P.; Verschoor, L.; van Dongen, K.J.; del Pozo, E.;NEnglJMed,1985
3. The response of serum growth hormone levels to the long-acting somatostatin analog SMS 201-995 in acromegaly;Comi, R.J.; Gorden, P.;J Clin Endocrinol Metab,1987
4. The effect of subcutaneous infusion versus subcutaneous injections of a somatostatin analogue (SMS 201-995) on the diurnal GH profile in acromegaly;Timsit, J.; Chanson, P.; Larger, E.;Acia Endocrinol (Copenh),1987
5. Spinal cord compression by amyloid tissue;McAnena, O.J.; Feely, M.P.; Kealy, W.F.;J Neurol Neurosurg Psvchiatry,1982